# A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

> **NCT05287126** · PHASE2 · RECRUITING · sponsor: **Pfizer** · enrollment: 36 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Etrasimod

## Key facts

- **NCT ID:** NCT05287126
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-16
- **Primary completion:** 2029-06-16
- **Final completion:** 2033-07-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287126, "A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT05287126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*